Ribavirin News and Research

RSS
Ribavirin, also known as Copegus, Rebetol, Virazole, or a component of Rebetron, is a type of antiviral medicine called a nucleoside analogue. This medicine blocks the ability of the hepatitis C virus (HCV) to make more copies of itself. Ribavirin is not active against HIV. Ribavirin is used in combination with interferon alfa-2a or -2b or peginterferon alfa-2a or -2b to treat HIV infected patients who are also infected with HCV.
Cure for hepatitis C

Cure for hepatitis C

Peregrine Pharmaceuticals to initiate new Bavituximab HCV trial

Peregrine Pharmaceuticals to initiate new Bavituximab HCV trial

New test for liver disease

New test for liver disease

Liver center leading record number of studies to tackle hepatitis C

Liver center leading record number of studies to tackle hepatitis C

Rabies kills three despite proven experimental treatment

Rabies kills three despite proven experimental treatment

Human Genome Sciences reports results of phase 2b trial of Albuferon

Human Genome Sciences reports results of phase 2b trial of Albuferon

Intarcia Therapeutics announces results from study of injectable Omega Interferon plus Ribavirin for treatment of hepatitis C genotype-1

Intarcia Therapeutics announces results from study of injectable Omega Interferon plus Ribavirin for treatment of hepatitis C genotype-1

Schering-Plough commits to chronic hepatitis C research

Schering-Plough commits to chronic hepatitis C research

Antipodean Pharma commences phase 2 trial in hepatitis C

Antipodean Pharma commences phase 2 trial in hepatitis C

Liver damage can be reversed

Liver damage can be reversed

Treatments used for SARS no benefit to victims

Treatments used for SARS no benefit to victims

SARS: Systematic review of treatment effects

SARS: Systematic review of treatment effects

Racial differences in hepatitis C viral responses

Racial differences in hepatitis C viral responses

Statins stop the replication of the hepatitis C virus

Statins stop the replication of the hepatitis C virus

Impact of obesity on treatment of chronic hepatitis C

Impact of obesity on treatment of chronic hepatitis C

Organ-recipients' deaths prompt call for suppliers of pet rodents to screen for lymphocytic choriomeningitis virus

Organ-recipients' deaths prompt call for suppliers of pet rodents to screen for lymphocytic choriomeningitis virus

Largest U.S. hepatitis C trial yields treatment insights

Largest U.S. hepatitis C trial yields treatment insights

Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation

Cyclosporine suppresses hepatitis C virus and increases the chance of a sustained virological response after liver transplantation

Limitation of combination therapy of Interferon and Ribavirin for older patients with chronic hepatitis C

Limitation of combination therapy of Interferon and Ribavirin for older patients with chronic hepatitis C

Largest hepatitis-C U.S. study defines optimal therapy

Largest hepatitis-C U.S. study defines optimal therapy